Tripelennamine

255.36

255.36

202-100-1

3C5ORO99TY

118946

DTXSID8023717

YELLOW OIL

D - Dermatologicals|R - Respiratory system

19.4

3.3

Tripelenamine is an oily liquid with an amine odor. (NTP, 1992)

1.0683 (rough estimate)

182-184 °C

19.3-20.5 °C @ Press: 5 Torr

nD25 1.5759-1.5765

H2O: 587 g/L (25 ºC)

LD50 oral in mouse: 152mg/kg

AMINE ODOR

PKB= 4.93

MP: 106-110 °C; LESS BITTER THAN HYDROCHLORIDE; 1% AQ SOLN HAS PH OF 4.25; FREELY SOL IN WATER, ALCOHOL; VERY SLIGHTLY SOL IN ETHER; PRACTICALLY INSOL IN BENZENE, CHLOROFORM /CITRATE/|WHITE POWDER /CITRATE; HYDROCHLORIDE/|CRYSTALS; MP: 192.5-193.5 °C; MAX ABSORPTION (WATER): 244, 305 NM (E= 4470, 4780); ABOUT NEUTRAL TO LITMUS; PH OF AQ SOLN CONTAINING 25 MG/ML: 6.71; 50 MG/ML: 6.67; 100 MG/ML: 5.56 /HYDROCHLORIDE/

Water soluble.

Amines, Phosphines, and Pyridines

TRIPELENAMINE neutralizes acids in exothermic reactions to form salts plus water. May be incompatible with isocyanates, halogenated organics, peroxides, phenols (acidic), epoxides, anhydrides, and acid halides. Flammable gaseous hydrogen may be generated in combination with strong reducing agents, such as hydrides.

Stable. Incompatible with strong oxidizing agents.

P201, P202, P260, P261, P264, P270, P271, P273, P280, P281, P301+P312, P304+P340, P305+P351+P338, P308+P313, P310, P311, P314, P321, P330, P391, P403+P233, P405, P501

H302

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

Manufacturers, packers, and distributors of drug and drug products for human use are responsible for complying with the labeling, certification, and usage requirements as prescribed by the Federal Food, Drug, and Cosmetic Act, as amended (secs 201-902, 52 Stat. 1040 et seq., as amended; 21 U.S.C. 321-392).

Flash point data for this chemical are not available. It is probably combustible. (NTP, 1992)

|Danger|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P201, P202, P260, P261, P264, P270, P271, P273, P280, P281, P301+P312, P304+P340, P305+P351+P338, P308+P313, P310, P311, P314, P321, P330, P391, P403+P233, P405, and P501|Aggregated GHS information provided by 24 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Fires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)

SMALL SPILLS AND LEAKAGE: If you should spill this chemical, use absorbent paper to pick up all liquid spill material. Seal the absorbent paper, as well as any of your clothing which may be contaminated, in a vapor-tight plastic bag for eventual disposal. Wash any surfaces you may have contaminated with a strong soap and water solution. Do not reenter the contaminated area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned. STORAGE PRECAUTIONS: You should store this material in a refrigerator. (NTP, 1992)

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

Symptoms of overdose include clumsiness or unsteadiness, convulsions, drowsiness, dryness of mouth, nose, or throat, feeling faint, flushing or redness of face, hallucinations, muscle spasms (especially of neck and back), restlessness, shortness of breath or troubled breathing, shuffling walk, tic-like movements of head and face, trembling and shaking of hands and trouble in sleeping.

Concurrent use /of ototoxic medications/ with antihistamines may mask the symptoms of ototoxicity such as tinnitus, dizziness, or vertigo. /Antihistamines/|Concurrent use of monoamine oxidase (MAO) inhibitors with antihistamines may prolong and intensify the anticholinergic and CNS depressant effects of antihistamines; concurrent use is not recommended. /Antihistamines/|Concurrent use /with alcohol or other CNS depression-producing medications/ may potentiate the CNS depressant effects of either these medications or antihistamines; also, concurrent use of maprotiline or tricyclic antidepressants may potentiate the anticholinergic effects of either antihistamines or these medications. /Antihistamines/|Anticholinergic effects may be potentiated when /anticholinergics or other medications with anticholinergic activity/ are used concurrently with antihistamines; patients should be advised to report occurrence of gastrointestinal problems promptly since paralytic ileus may occur with concurrent therapy. /Antihistamines/|For more Interactions (Complete) data for TRIPELENNAMINE (6 total), please visit the HSDB record page.

Used for the symptomatic relief of hypersensitivity reactions, coughs, and the common cold.

Anti-Allergic Agents; Histamine H1 Antagonists|Antihistamines are indicated in the prophylactic and symptomatic treatment of perennial and seasonal allergic rhinitis, vasomotor rhinitis, and allergic conjunctivitis due to inhalant allergens and foods. /Antihistamines; Included in US product labeling/|Antihistamines are indicated for the symptomatic treatment of pruritus associated with allergic reactions and of mild, uncomplicated allergic skin manifestations of urticaria and angioedema, in dermatographism, and in urticaria associated with transfusions. /Antihistamines; Included in US product labeling/|Antihistamines are also used in the treatment of pruritus associated with pityriasis rosea. /Antihistamines; NOT included in US product labeling/|For more Therapeutic Uses (Complete) data for TRIPELENNAMINE (8 total), please visit the HSDB record page.

Use is not recommended in newborn or premature infants because this age group has an increased susceptibility to anticholinergic side effects, such as central nervous system excitation, and an increased tendency toward convulsions. A paradoxical reaction characterized by hyperexcitability may occur in children taking antihistamines. /Antihistamines/|Dizziness, sedation, confusion, and hypotension may be more likely to occur in geriatric patients taking antihistamines. Geriatric patients are especially susceptible to the anticholinergic side effects, such as dryness of mouth and urinary retention (especially in males), of the antihistamines. If these side effects occur and continue or are severe, medication should probably be discontinued. /Antihistamines/|Prolonged use of antihistamines ... may decrease or inhibit salivary flow, thus contributing to the development of caries, periodontal disease, oral candidiasis, and discomfort. /Antihistamines/|BIOAVAILABILITY OF DRUG IN TIMED-RELEASE FORM MAY BE NEITHER UNIFORM NOR RELIABLE. /HYDROCHLORIDE/|For more Drug Warnings (Complete) data for TRIPELENNAMINE (16 total), please visit the HSDB record page.

5(?). 5= EXTREMELY TOXIC: PROBABLE ORAL LETHAL DOSE (HUMAN) 5-50 MG/KG, BETWEEN 7 DROPS & 1 TEASPOONFUL FOR 70 KG PERSON (150 LB). /HYDROCHLORIDE/

Used to treat the effects of colds and allergies. Tripelennamine is an antihistamine. Histamine, acting on H₁-receptors, produces pruritis, vasodilatation, hypotension, flushing, headache, tachycardia, and bronchoconstriction. Histamine also increases vascular permeability and potentiates pain. Tripelennamine is a histamine H1 antagonist. It competes with histamine for the normal H₁-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. It provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)|Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)

Well absorbed in the digestive tract.|The H1 antagonists are well absorbed from the gi tract. Following oral administration, peak plasma concn are achieved in 2 to 3 hr and effects usually last 4 to 6 hr; however, some of the drugs are much longer acting ... . /Histamine Antagonists: H1 Antagonists/|... H1 antagonists are eliminated more rapidly by children than by adults and more slowly in those with severe liver disease. /Histamine Antagonists: H1 Antagonists/

Hepatic|FROM URINE OF HUMAN ORALLY ADMIN TRIPELENNAMINE, MINOR METAB IDENTIFIED AS N-OXIDE, MAJOR CONJUGATE WAS A UNIQUE QUATERNARY AMMONIUM N-GLUCURONIDE, 2 OTHERS WERE O-GLUCURONIDE OF HYDROXYLATED DERIV. GLUCURONIDE OF HYDROXYTRIPELENNAMINE BEING PRINCIPAL METAB.|MAIN SITE OF METABOLIC TRANSFORMATION IS LIVER. /ANTIHISTAMINES/|H1 blockers are among the many drugs that induce hepatic microsomal enzymes, and they may facilitate their own metabolism. /Histamine Antagonists: H1 Antagonists/|Tripelennamine has known human metabolites that include Tripelennamine N-glucuronide.

Tripelennamine binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.|Antihistamines used in the treatment of allergy act by competing with histamine for H1-receptor sites on effector cells. They thereby prevent, but do not reverse, responses mediated by histamine alone. Antihistamines antagonize, in varying degrees, most of the pharmacological effects of histamine, including urticaria and pruritus. Also, the anticholinergic actions of most antihistamines provide a drying effect on the nasal mucosa. /Antihistamines/|H1 antagonists inhibit most responses of smooth muscle to histamine. Antagonism of the constrictor action of histamine on respiratory smooth muscle is easily shown in vivo and in vitro. /Histamine Antagonists: H1 Antagonists/|H1 antagonists strongly block the action of histamine that results in increased permeability and formation of edema and wheal. /Histamine Antagonists: H1 Antagonists/|Within the vascular tree, the H1 antagonists inhibit both the vasoconstrictor effects of histamine and, to a degree, the more rapid vasodilator effects that are mediated by H1 receptors on endothelial cells. Residual vasodilatation reflects the involvement of H2 receptors on smooth muscle and can be suppressed only by the concurrent administration of an H2 antagonist. Effects of the histamine antagonists on histamine induced changes in systemic blood pressure parallel these vascular effects. /Histamine Antagonists: H1 Antagonists/|Many of the H1 antagonists tend to inhibit responses to acetylcholine that are mediated by muscarinic receptors. These atropine like actions are sufficiently prominent in some of the drugs to be manifest during clinical usage ... . /Histamine Antagonists: H1 Antagonists/

SYMPTOMS: Symptoms of exposure to this compound may include euphoria, aplastic anemia, excitement, hallucinations, ataxia, incoordination, athetosis, convulsions, postictal depression, dry mouth, fixed dilated pupils, flushing of the face, fever, central nervous system depression, drowsiness and coma. (NTP, 1992)

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop. SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment. INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing. INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)

THERE IS NO SPECIFIC THERAPY FOR ANTIHISTAMINE POISONING, AND TREATMENT IS ALONG GENERAL SYMPTOMATIC AND SUPPORTIVE LINES. ... SHOULD BREATHING FAIL, MECH SUPPORT OF VENTILATION OFFER SAFER AND ... EFFECTIVE MEANS OF MAINTAINING RESP THAN USE OF ANALEPTICS WHICH ARE PRONE TO INITIATE OR INTENSIFY CONVULSIVE PHASE. /ANTIHISTAMINES/

IN CASES OF SYSTEMIC POISONING FROM OVERDOSAGE, OCULAR EFFECTS HAVE BEEN RARE, BUT ISOLATED INSTANCES OF NYSTAGMUS & STRABISMUS HAVE BEEN NOTED, & PUPILS MAY BE DILATED & POORLY RESPONSIVE TO LIGHT.|UNUSUAL CASE OF POISONING BY PYRIBENZAMINE FOLLOWED PERCUTANEOUS APPLICATION OF 2.14 G OF DRUG AS AEROSOL SPRAY ON 8-YR-OLD BOY WITH SEVERE POISON IVY OF TRUNK & EXTREMITIES.|...RIGIDITY, STUPOR, & CIRCULATORY COLLAPSE ARE DESCRIBED IN HUMAN POISONINGS. /HYDROCHLORIDE/|...GI IRRITATION IS COMMON, BUT NOT SEVERE; SEDATION IS MODERATE, & CNS STIMULATION OCCURS OCCASIONALLY. /HYDROCHLORIDE/|For more Human Toxicity Excerpts (Complete) data for TRIPELENNAMINE (13 total), please visit the HSDB record page.

Azaron

ESSENTIALLY 100% AS AN ANTIHISTAMINIC AGENT (AS CITRATE & HYDROCHLORIDE)

ELIXIR 37.5 MG (EQUIV TO 25 MG OF HYDROCHLORIDE SALT)/5 ML. /CITRATE/|GENERIC: TABLETS, POWDER, CREAM; PBZ-SR (GEIGY) TABLETS (TIMED-RELEASE) 100 MG; PYRIBENZAMINE HYDROCHLORIDE (CIBA): TABLETS 25 & 50 MG, TABLETS (TIMED-RELEASE) 50 MG, CREAM 2% IN 1 OZ CONTAINERS, OINTMENT 2% IN 1 OZ CONTAINERS. /HYDROCHLORIDE/

GAS CHROMATOGRAPHIC DETERMINATION OF TRACES OF TRIPELENNAMINE IN PHARMACEUTICAL PREPN.

TLC DETECTION OF TRIPELENNAMINE IN DRUG ABUSE URINE SCREENING PROGRAMS.|GC METHOD FOR DETECTION & QUALITATIVE ANALYSIS OF BASIC DRUGS IN POSTMORTEM BLOOD, USING A NITROGEN PHOSPHORUS DETECTOR.

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients|Pharmaceuticals